SG11201809388SA - Relative potency assay for viral vector encoding isomerohydrolases - Google Patents
Relative potency assay for viral vector encoding isomerohydrolasesInfo
- Publication number
- SG11201809388SA SG11201809388SA SG11201809388SA SG11201809388SA SG11201809388SA SG 11201809388S A SG11201809388S A SG 11201809388SA SG 11201809388S A SG11201809388S A SG 11201809388SA SG 11201809388S A SG11201809388S A SG 11201809388SA SG 11201809388S A SG11201809388S A SG 11201809388SA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rule
- applicant
- assay
- lots
- Prior art date
Links
- 238000003556 assay Methods 0.000 title abstract 4
- 239000013603 viral vector Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 abstract 1
- 102100031176 Retinoid isomerohydrolase Human genes 0.000 abstract 1
- 239000013592 cell lysate Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3819—Affinity chromatography of the nucleic acid-nucleic acid binding protein type
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01135—Phosphatidylcholine--retinol O-acyltransferase (2.3.1.135)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01064—Retinoid isomerohydrolase (3.1.1.64)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662328916P | 2016-04-28 | 2016-04-28 | |
| PCT/US2017/030254 WO2017190081A1 (en) | 2016-04-28 | 2017-04-28 | Relative potency assay for viral vector encoding isomerhydrolases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809388SA true SG11201809388SA (en) | 2018-11-29 |
Family
ID=60161213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809388SA SG11201809388SA (en) | 2016-04-28 | 2017-04-28 | Relative potency assay for viral vector encoding isomerohydrolases |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20210348210A1 (ru) |
| EP (1) | EP3448371A4 (ru) |
| JP (1) | JP7067843B2 (ru) |
| KR (1) | KR20190020661A (ru) |
| CN (1) | CN109689033A (ru) |
| AU (2) | AU2017258776B2 (ru) |
| BR (1) | BR112018072268A2 (ru) |
| CA (1) | CA3022386A1 (ru) |
| CL (1) | CL2018003079A1 (ru) |
| CO (1) | CO2018012509A2 (ru) |
| IL (1) | IL262583B2 (ru) |
| MX (1) | MX2018013205A (ru) |
| MY (1) | MY194096A (ru) |
| PE (1) | PE20190393A1 (ru) |
| PH (1) | PH12018502291A1 (ru) |
| RU (1) | RU2756403C2 (ru) |
| SG (1) | SG11201809388SA (ru) |
| WO (1) | WO2017190081A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240060989A1 (en) | 2019-10-04 | 2024-02-22 | Novartis Ag | Methods for measuring cralbp activity |
| WO2023099793A1 (en) * | 2021-12-03 | 2023-06-08 | Dsm Ip Assets B.V. | Novel compositions comprising retinoids |
| WO2023099791A1 (en) * | 2021-12-03 | 2023-06-08 | Dsm Ip Assets B.V. | Novel compositions comprising trans retinol |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU873121A1 (ru) * | 1979-08-20 | 1981-10-15 | Институт биохимии АН ЛитССР | Способ определени активности гидролаз |
| DE69719528T2 (de) * | 1996-09-27 | 2003-11-06 | Unilever Nv | Hautpflegemittel enthaltend kombinationen aus verbindungen die die wirkungvon retinsaüre auf der haut nachbilden |
| US6071410A (en) * | 1998-11-16 | 2000-06-06 | Varian, Inc. | Recovery of organic solutes from aqueous solutions |
| CN1997359A (zh) * | 2004-02-17 | 2007-07-11 | 哈佛大学校长及研究员协会 | 包括黄斑变性在内的眼科疾病的处理 |
| ES2752924T3 (es) * | 2004-06-18 | 2020-04-06 | Univ Washington | Derivados de retinal y métodos de uso de los mismos para el tratamiento de trastornos visuales |
| US20080249042A1 (en) * | 2004-09-09 | 2008-10-09 | University Of Washington | All-Trans-Retinol: All-Trans-13,14-Dihydroretinol Saturase and Methods of Its Use |
| CA2774168C (en) * | 2009-09-15 | 2021-02-23 | Ronald Erwin Boch | Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle |
| US20140357611A1 (en) * | 2009-12-08 | 2014-12-04 | Case Western Reserve University | Compounds and methods of treating ocular disorders |
| ES2897508T3 (es) * | 2013-05-31 | 2022-03-01 | Univ California | Variantes de virus adenoasociados y métodos de uso de las mismas |
| US10471118B2 (en) * | 2014-05-30 | 2019-11-12 | Case Western Reserve University | Retinylamine derivitives for treatment of ocular disorders |
| WO2016018816A1 (en) * | 2014-07-31 | 2016-02-04 | The Board Of Regents Of The University Of Oklahoma | High isomerohydrolase activity mutants of mammalian rpe65 |
| GB201502137D0 (en) * | 2015-02-09 | 2015-03-25 | Ucl Business Plc | Treatment |
-
2017
- 2017-04-28 SG SG11201809388SA patent/SG11201809388SA/en unknown
- 2017-04-28 KR KR1020187034586A patent/KR20190020661A/ko not_active IP Right Cessation
- 2017-04-28 US US16/096,673 patent/US20210348210A1/en active Pending
- 2017-04-28 BR BR112018072268-5A patent/BR112018072268A2/pt active Search and Examination
- 2017-04-28 RU RU2018141675A patent/RU2756403C2/ru active
- 2017-04-28 PE PE2018002238A patent/PE20190393A1/es unknown
- 2017-04-28 IL IL262583A patent/IL262583B2/en unknown
- 2017-04-28 JP JP2018555878A patent/JP7067843B2/ja active Active
- 2017-04-28 MY MYPI2018001807A patent/MY194096A/en unknown
- 2017-04-28 AU AU2017258776A patent/AU2017258776B2/en active Active
- 2017-04-28 CN CN201780040688.8A patent/CN109689033A/zh active Pending
- 2017-04-28 MX MX2018013205A patent/MX2018013205A/es unknown
- 2017-04-28 CA CA3022386A patent/CA3022386A1/en active Pending
- 2017-04-28 WO PCT/US2017/030254 patent/WO2017190081A1/en active Application Filing
- 2017-04-28 EP EP17790597.3A patent/EP3448371A4/en active Pending
-
2018
- 2018-10-26 PH PH12018502291A patent/PH12018502291A1/en unknown
- 2018-10-29 CL CL2018003079A patent/CL2018003079A1/es unknown
- 2018-11-22 CO CONC2018/0012509A patent/CO2018012509A2/es unknown
-
2023
- 2023-06-22 AU AU2023203939A patent/AU2023203939A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3448371A1 (en) | 2019-03-06 |
| WO2017190081A1 (en) | 2017-11-02 |
| JP7067843B2 (ja) | 2022-05-16 |
| AU2017258776A1 (en) | 2018-11-29 |
| EP3448371A4 (en) | 2019-09-11 |
| RU2756403C2 (ru) | 2021-09-30 |
| KR20190020661A (ko) | 2019-03-04 |
| PH12018502291A1 (en) | 2019-07-08 |
| CO2018012509A2 (es) | 2019-04-30 |
| IL262583A (en) | 2018-12-31 |
| CA3022386A1 (en) | 2017-11-02 |
| MY194096A (en) | 2022-11-11 |
| BR112018072268A2 (pt) | 2019-02-12 |
| CN109689033A (zh) | 2019-04-26 |
| AU2023203939A1 (en) | 2023-09-14 |
| RU2018141675A3 (ru) | 2020-09-14 |
| MX2018013205A (es) | 2019-06-24 |
| IL262583B2 (en) | 2023-10-01 |
| IL262583B1 (en) | 2023-06-01 |
| AU2017258776B2 (en) | 2023-07-13 |
| RU2018141675A (ru) | 2020-05-29 |
| PE20190393A1 (es) | 2019-03-13 |
| US20210348210A1 (en) | 2021-11-11 |
| CL2018003079A1 (es) | 2019-03-29 |
| JP2019514375A (ja) | 2019-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810327XA (en) | Single domain serum albumin binding protein | |
| SG11201809381XA (en) | Polynucleotides encoding interleukin-12 (il12) and uses thereof | |
| SG11201909205YA (en) | Immunoconjugates of an anti-pd-1 antibody with a mutant il-2 or with il-15 | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201805532XA (en) | Multivalent and multispecific 41bb-binding fusion proteins | |
| SG11201805186VA (en) | Compositions and methods for immune cell modulation in adoptive immunotherapies | |
| SG11201805136TA (en) | Group b adenovirus encoding an anti-tcr-complex antibody or fragment | |
| SG11201811270WA (en) | Systems and methods for trajectory determination | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201803983UA (en) | Transformable tagging compositions, methods, and processes incorporating same | |
| SG11201407508RA (en) | Encoding and decoding based on blending of sequences of samples along time | |
| SG11202000105QA (en) | Anti-cd166 antibodies and uses thereof | |
| SG11201903825SA (en) | Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion | |
| SG11201900743UA (en) | Multiple function exercise device | |
| SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
| SG11201808797XA (en) | T cell receptors | |
| SG11201901221YA (en) | Methods for detecting aav | |
| SG11201907023UA (en) | Method of reducing neutropenia | |
| SG11201807780XA (en) | Customizable facility | |
| SG11201807881VA (en) | Compositions and methods for making antibodies based on use of an expression-enhancing locus | |
| SG11201908624SA (en) | Aryl hydrocarbon receptor antagonists and uses thereof | |
| SG11202000312UA (en) | Encapsulated polynucleotides and methods of use | |
| SG11201908238SA (en) | Anti-c5 antibodies and uses thereof | |
| SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
| SG11201809751XA (en) | Egfr inhibitor compounds |